in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
in chloroform-d1
1 equiv. of the free ligand was added to a CDCl3 soln. of Pd-complex at 20°C, reaction was monitored by (1)H NMR spectroscopy; equil. const. is given; (1)H NMR spectral data;
